Subjects
We are here for you
Personalized Care
Dedicated Support
Patient-Centered Approach
Beneficios de unirse a un estudio
Los participantes recibirán una compensación
Las cantidades pueden variar según el estudio en el que participen.
No necesitas un seguro médico para participar
No se necesita pago ni seguro médico para participar en ningún ensayo clÃnico.
Acceso a nuevos medicamentos y tratamientos exclusivos
Obtenga acceso a nuevos medicamentos sin pagar nada
Contribuye a la ciencia y por lo tanto a la comunidad
Puedes marcar la diferencia en el estudio de las enfermedades y ayudar a otras personas a tener una mejor calidad de vidaÂ
Únete a un estudio ahora
Life Medical Research Group Corp invites you to participate in our clinical studies and help drive medical innovation. By joining a study, you can gain exclusive access to cutting-edge medications and treatments for diseases affecting thousands of people as well as receiving monetary compensation for your time. Your participation will contribute significantly to advancing healthcare and making a positive impact on the world. With our team of top specialists and state-of-the-art facilities, we ensure a safe and supportive environment for all participants. Don’t wait—be a part of the future of medicine today.
Life Medical Research Group
Enrolling Trials
ALZHEIMER'S disease
COVID-19
OBESITY
Asthma
Eczema
Osteoartritis
rheumatoid arthritis
SJÖGREN'S SYNDROME
fatty liver disease (nash)
PARKINSON'S DISEASE
DERMATITIS
COPD
Influenza
DEPRESSION
CIRRHOSIS
NATIVE3:
NASH Trial
We are currently enrolling participants aged 18 and older for a Phase III clinical trial focused on Nonalcoholic Steatohepatitis (NASH). This study aims to evaluate the safety and effectiveness of an investigational treatment for individuals diagnosed with NASH. Qualified participants will receive study-related care and monitoring from experienced medical professionals at no cost.
SYNCHRONY HISTOLOGY:
NASH/ MASH Trial
We are currently enrolling participants from 18 to 80 years old for a Phase III clinical trial focused on Nonalcoholic Steatohepatitis (NASH/MASH). This study aims to evaluate the safety and effectiveness of an investigational treatment for individuals diagnosed with NASH. Qualified participants will receive study-related care and monitoring from experienced medical professionals at no cost.
SYNCHRONY OUTCOMES:
Compensated Cirrhosis due to NASH/ MASH Trial
We are currently enrolling participants from 18 to 80 years old for a Phase III clinical trial focused on compensated cirrhosis due to Nonalcoholic Steatohepatitis (NASH/MASH). This study aims to evaluate the safety and effectiveness of an investigational treatment for individuals diagnosed with NASH and compensated cirrhosis. Qualified participants will receive study-related care and monitoring from experienced medical professionals at no cost.
Sjögren's Syndrome Trial
We are currently enrolling female participants from 18 to 75 years old for a Phase II clinical trial focused on Sjögren's syndrome. This study aims at improving moderate to severe symptoms of fatigue, dryness and/or pain related to this disease. Qualified participants will receive study-related care and monitoring from experienced medical professionals at no cost.
RENEW-MDD-1
Major Depressive Disorder (MDD)
We are currently enrolling males and females participants from 18 to 75 years old for a Phase III clinical trial focused on MDD. This is a study for adults with major depressive disorder who are taking a treatment that is helping manage their symptoms. Qualified participants will receive study-related care and monitoring from experienced medical professionals at no cost.